Back to search results

Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes

This study is looking for adults aged 30-65 with Type 1 Diabetes (T1D), Latent Autoimmune Diabetes in Adults (LADA), or diabetes due to Pancreatitis, who currently exercise less than once a week. The goal is to help you exercise more often and with more confidence. You'll receive a free Garmin smartwatch and a program membership that includes exercise coaching and personalized feedback about how your insulin, carbohydrates, exercise, sleep, and blood sugar are connected. You'll also wear the fitness watch and keep a daily health diary. The study will measure how long you exercise each week over 20 weeks to see if the program helps. This is a remote study, so you don't need to live in Connecticut.

Study design
This interventional study plans to enroll 60 participants. It is designed to test a behavioral intervention to improve exercise habits.
What's involved
You will wear a fitness watch and keep a daily health diary. The study will last for at least 20 weeks.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint is measured at 20 weeks, indicating follow-up for at least that duration.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06967701

Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes

Recruiting
NAAges 30–65InterventionalSupportive care
Yale University
~60 participants
Updated 2026-07-22 on ClinicalTrials.gov
What's tested:Exercise programSelf-monitoring

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Weekly exercise duration
Measured over 20 weeks

Conditions

Type 1 Diabetes (T1D)
Latent Autoimmune Diabetes in Adult (LADA)
Pancreatitis

Explore related trials

Latent Autoimmune Diabetes in AdultsPancreatitisType 1 Diabetes Mellitus

Where it's being run

1 sites across 1 states
Connecticut1

Study leadership

  • Garrett Ash, PhD, CSCS · PRINCIPAL_INVESTIGATOR · Yale University

Who to contact

Yashvi Verma, BS
[email protected]
203-444-0678
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

30-65 years old inclusive
Diagnosis with type 1 diabetes (T1D) or other insulin deficiency diabetes (latent autoimmune disease of adulthood, diabetes secondary to pancreatitis)
Less than 1.0 exercise sessions per week
Smartphone ownership
English literacy
Under regular care by a healthcare provider (1+ appointments per year)
Home Broadband wireless Internet or cell phone network
Using continuous glucose monitor (CGM) and sharing data with medical record for at least 6 weeks
Using insulin pump or pen and sharing data with medical record for at least 6 weeks

Exclusion

Diabetic ketoacidosis not clearly related to pump site failure in past 6 months
\>1 episode of severe hypoglycemia (altered mental and/or physical status requiring assistance from another person for recovery) in past 6 months
A1c ≥10.0%
Resting blood pressure \>160mmHg systolic or \>100 mmHg diastolic.
Myocardial infarction or angina in past 12 months
Uncontrolled arrhythmia (e.g., atrial fibrillation with rapid ventricular response, new onset atrial fibrillation, ventricular tachycardia, escape rhythms)
Congestive heart failure (stage 3 or 4)
Exercise-induced asthma (not controlled on inhalers)
Chronic obstructive pulmonary disease (requiring home oxygen)
Renal failure
Pregnancy
Cognitive impairment
Severe retinopathy or neuropathy.
Other chronic disease or physical disability that would influence exercise intervention (e.g., recent spinal surgery)

What this trial measures

  • Weekly exercise duration20 weeks

    Minutes/week. Measured by blinded hip watch and periodic interviews. 0 minutes/week is the lowest value, 150 minutes/week meets clinically recommended amounts.